Previous Section
Clinical Trials
21. Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.
- Author
- Bennouna J; Breton JL; Tourani JM; Ottensmeier C; O'Brien M; Kosmidis P; Huat TE; Pinel MC; Colin C; Douillard JY;
- Institution
- Centre Rene Gauducheau, Boulevard Jacques Monod, Saint-Herblain 44805, France. j-bennouna@nantes.fnclcc.fr
- Journal
- Br J Cancer. 2006 May 22;94(10):1383-8.
- Abstract URL
- Click here to view abstract
22. A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer.
- Author
- Suzuki R; Hasegawa Y; Baba K; Saka H; Saito H; Taniguchi H; Yamamoto M; Matsumoto S; Kato K; Oishi T; Imaizumi K; Shimokata K;
- Institution
- Toyohashi Municipal Hospital, 50 Hachiken-nishi, Aotake, Toyohashi, Aichi 441-8570, Japan. rsuzuki-alg@umin.ac.jp
- Journal
- Br J Cancer. 2006 Jun 5;94(11):1599-603.
- Abstract URL
- Click here to view abstract
23. Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancer.
- Author
- Ramlau R; Gervais R; Krzakowski M; von Pawel J; Kaukel E; Abratt RP; Dharan B; Grotzinger KM; Ross G; Dane G; Shepherd FA;
- Institution
- Regional Lung Disease Centre, Oncology Department, Poznan, Poland. rramlau@wcchpig.pl
- Journal
- J Clin Oncol. 2006 Jun 20;24(18):2800-7. Epub 2006 May 8.
- Abstract URL
- Click here to view abstract
24. Phase I/II study of gemcitabine and epirubicine in stage IIIB-IV non small cell lung cancer.
- Author
- Illiano A; Battiloro C; Formato R; Danilo R; Tortoriello A; Caponigro F; Iaffaioli RV;
- Institution
- Pneumoncology Monaldi H., Naples, Italy.
- Journal
- Front Biosci. 2006 Sep 1;11:2349-53.
- Abstract URL
- Click here to view abstract
25. Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984).
- Author
- Biesma B; Manegold C; Smit HJ; Willems L; Legrand C; Passioukov A; van Meerbeeck JP; Giaccone G;
- Institution
- Afdeling Longziekten, Jeroen Bosch Ziekenhuis, Nieuwstraat 34, 5211 NL's-Hertogenbosch, The Netherlands. b.biesma@jbz.nl
- Journal
- Eur J Cancer. 2006 Jul;42(10):1399-406. Epub 2006 Jun 8.
- Abstract URL
- Click here to view abstract
26. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
- Author
- Gridelli C; Maione P; Illiano A; Piantedosi FV; Favaretto A; Bearz A; Robbiati SF; Filipazzi V; Lorusso V; Carrozza F; Iaffaioli RV; Manzione L; Gallo C; Morabito A; Perrone F;
- Institution
- Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy. cgridelli@libero.it
- Journal
- J Clin Oncol. 2007 Oct 10;25(29):4663-9.
- Abstract URL
- Click here to view abstract
27. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
- Author
- Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
- Institution
- National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada.
- Journal
- J Clin Oncol. 2008 Jan 1;26(1):54-9.
- Abstract URL
- Click here to view abstract
28. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
- Author
- Ramalingam SS; Dahlberg SE; Langer CJ; Gray R; Belani CP; Brahmer JR; Sandler AB; Schiller JH; Johnson DH;
- Institution
- Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA. suresh.ramalingam@emory.edu
- Journal
- J Clin Oncol. 2008 Jan 1;26(1):60-5.
- Abstract URL
- Click here to view abstract
29. The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
- Author
- Davies AM; Ruel C; Lara PN; Lau DH; Gumerlock PH; Bold R; Shibata S; Lenz HJ; Schenkein DP; Gandara DR;
- Institution
- Division of Hematology and Oncology, Davis Cancer Center, University of California, Sacramento, California 95817, USA. angela.davies@ucdmc.ucdavis.edu
- Journal
- J Thorac Oncol. 2008 Jan;3(1):68-74.
- Abstract URL
- Click here to view abstract
30. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.
- Author
- Lara PN Jr; Redman MW; Kelly K; Edelman MJ; Williamson SK; Crowley JJ; Gandara DR;
- Institution
- University of California Davis Cancer Center, 4501 X St, Sacramento, CA 95817, USA. primo.lara@ucdmc.ucdavis.edu
- Journal
- J Clin Oncol. 2008 Jan 20;26(3):463-7.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
